Blueprint Medicines Corporation (LON:0HOJ)
London flag London · Delayed Price · Currency is GBP · Price in USD
129.31
+0.02 (0.01%)
At close: Jul 11, 2025

Blueprint Medicines Market Cap

Blueprint Medicines has a market cap or net worth of 6.20 billion as of July 11, 2025. Its market cap has increased by 17.78% in one year.

Market Cap
6.20B
Enterprise Value
6.06B
Revenue
435.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
129.31

Market Cap Chart

Since April 30, 2015, Blueprint Medicines's market cap has increased from 317.21M to 6.20B, an increase of 1,854.78%. That is a compound annual growth rate of 33.82%.

History

DateMarket Cap% Change
Jul 11, 2025 6.20B 40.10%
Dec 31, 2024 4.43B 0.54%
Dec 29, 2023 4.40B 102.36%
Dec 30, 2022 2.18B -53.26%
Dec 31, 2021 4.65B 1.67%
Dec 31, 2020 4.58B 53.82%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 164.77B
GSK plc 56.99B
Haleon 33.44B
Smith & Nephew 10.11B
ConvaTec Group 5.33B
Hikma Pharmaceuticals 4.40B
HUTCHMED (China) 1.98B
Oxford Nanopore Technologies 1.47B
Market Cap Rankings